These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35710071)

  • 21. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
    Halwani M; Yebio B; Suntres ZE; Alipour M; Azghani AO; Omri A
    J Antimicrob Chemother; 2008 Dec; 62(6):1291-7. PubMed ID: 18931388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fast Biofilm Penetration and Anti-PAO1 Activity of Nebulized Azithromycin in Nanoarchaeosomes.
    Altube MJ; Martínez MMB; Malheiros B; Maffía PC; Barbosa LRS; Morilla MJ; Romero EL
    Mol Pharm; 2020 Jan; 17(1):70-83. PubMed ID: 31617725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3-Amino-4-aminoximidofurazan derivatives: small molecules possessing antimicrobial and antibiofilm activity against Staphylococcus aureus and Pseudomonas aeruginosa.
    Das MC; Paul S; Gupta P; Tribedi P; Sarkar S; Manna D; Bhattacharjee S
    J Appl Microbiol; 2016 Apr; 120(4):842-59. PubMed ID: 26785169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa.
    Barraud N; Hassett DJ; Hwang SH; Rice SA; Kjelleberg S; Webb JS
    J Bacteriol; 2006 Nov; 188(21):7344-53. PubMed ID: 17050922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of the combination of tobramycin and a macrolide in an in vitro Pseudomonas aeruginosa mature biofilm model.
    Tré-Hardy M; Nagant C; El Manssouri N; Vanderbist F; Traore H; Vaneechoutte M; Dehaye JP
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4409-15. PubMed ID: 20696878
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Pinto RM; Monteiro C; Costa Lima SA; Casal S; Van Dijck P; Martins MCL; Nunes C; Reis S
    ACS Appl Mater Interfaces; 2021 Sep; 13(36):42329-42343. PubMed ID: 34464076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution and Inhibition of Liposomes on Staphylococcus aureus and Pseudomonas aeruginosa Biofilm.
    Dong D; Thomas N; Thierry B; Vreugde S; Prestidge CA; Wormald PJ
    PLoS One; 2015; 10(6):e0131806. PubMed ID: 26125555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
    Sanchez CJ; Akers KS; Romano DR; Woodbury RL; Hardy SK; Murray CK; Wenke JC
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4353-61. PubMed ID: 24841260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Smith S; Waters V; Jahnke N; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.
    Bala A; Kumar R; Harjai K
    J Med Microbiol; 2011 Mar; 60(Pt 3):300-306. PubMed ID: 21127154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of Pseudomonas aeruginosa biofilm formation by Vitexin: A combinatorial study with azithromycin and gentamicin.
    Das MC; Sandhu P; Gupta P; Rudrapaul P; De UC; Tribedi P; Akhter Y; Bhattacharjee S
    Sci Rep; 2016 Mar; 6():23347. PubMed ID: 27000525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa.
    Soren O; Rineh A; Silva DG; Cai Y; Howlin RP; Allan RN; Feelisch M; Davies JC; Connett GJ; Faust SN; Kelso MJ; Webb JS
    J Antimicrob Chemother; 2020 Jan; 75(1):117-125. PubMed ID: 31682251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved effect of amikacin-loaded poly(D,L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa.
    Sabaeifard P; Abdi-Ali A; Gamazo C; Irache JM; Soudi MR
    J Med Microbiol; 2017 Mar; 66(2):137-148. PubMed ID: 28260589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Albumin-coated pH-responsive dimeric prodrug-based nano-assemblies with high biofilm eradication capacity.
    Li X; Li W; Li K; Chen X; Wang C; Qiao M; Hong W
    Biomater Sci; 2023 Jan; 11(3):1031-1041. PubMed ID: 36545821
    [No Abstract]   [Full Text] [Related]  

  • 38. Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane.
    Imamura Y; Higashiyama Y; Tomono K; Izumikawa K; Yanagihara K; Ohno H; Miyazaki Y; Hirakata Y; Mizuta Y; Kadota J; Iglewski BH; Kohno S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1377-80. PubMed ID: 15793115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa.
    Saini H; Vadekeetil A; Chhibber S; Harjai K
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031194
    [No Abstract]   [Full Text] [Related]  

  • 40. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.
    Meers P; Neville M; Malinin V; Scotto AW; Sardaryan G; Kurumunda R; Mackinson C; James G; Fisher S; Perkins WR
    J Antimicrob Chemother; 2008 Apr; 61(4):859-68. PubMed ID: 18305202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.